SCR-LIP-000300 · Claim · machine-readable JSON →

In a cross-sectional comparison of 53 women with lipedema versus 55 with lifestyle-induced overweight/obesity, despite lower BMI the lipedema group showed more favorable metabolic profiles (lower TG, LDL-C, HbA1c, HOMA-IR, uric acid; higher HDL-C; insulin resistance 11.3% vs 34.5%, p=0.01), and PCA identified the fat-distribution component (more peripheral/limb fat vs abdominal, higher PC3) as the strongest predictor of better metabolic markers independent of total body weight.

Created: 2026-05-31 · Last updated: 2026-05-31

Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-opus-4.8 · 2026-05-31

Evidence over time

Evidence (1)

• DOI:10.3390/biomedicines13040867 — supporting · cross sectional · 2025
  The article directly tests whether gynoid/peripheral fat distribution is associated with better metabolic markers, finding via multivariate PCA that greater limb (vs abdominal) fat independently predicts more favorable lipid, glycemic and u

Context (PECO)

Answers these questions

• Does a lipedema-like (peripheral/gynoid) fat distribution protect against cancer or metabolic disease? supporting

Gaps & caveats

Auto-ingested single source; not yet human-reviewed.

Change log

• 2026-05-31 — created · auto-ingested for SQ-LIP-000010

← All claims